Prot# CLBH589B2201: A Phase II Study of Oral LBH589 in Adult Patients with Refractory Cutaneous T-Cell Lymphoma

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date3/13/0710/1/11

    Funding

    • Novartis Pharmaceuticals Corporation (CLBH589B2201)